EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Clinical trials for EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial offers hope for patients with untreatable blood cancer
Disease control Not yet recruitingThis is an early safety study testing a new cell therapy called SL4903 for adults with multiple myeloma that has come back or stopped responding to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target the cancer, and infuse them b…
Matched conditions: EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Radiation 'Priming' tested to supercharge cancer drug
Disease control Not yet recruitingThis study is testing whether giving low doses of radiation therapy before a new drug called elranatamab can help the drug work better against a hard-to-treat form of multiple myeloma. It will involve about 34 adults whose cancer has returned or stopped responding to standard tre…
Matched conditions: EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC